Israeli PM Netanyahu says he was diagnosed with early-stage prostate cancer; recently had a successful operation without metastases; asked for a delayed publication amid the war with Iran, Journalist Stein reports

Israeli PM Netanyahu's diagnosis of early-stage prostate cancer, amid ongoing tensions with Iran, could raise concerns about political stability in the region.

Newsquawk StaffPublished On the live feed at 7 more headlines followed before this page went public
Newsquawk headlinesUTC

Charter Communications (CHTR) Q1 2026 (USD): Basic EPS 9.27 (exp. 9.88), Revenue 13.6bln (exp. 13.55bln)

Procter & Gamble Company (PG) Q3 (USD) Adj. EPS 1.59 (exp. 1.56), Revenue 21.2 (exp. 20.57bln); P&G maintained its guidance range for fiscal 2026 all-in sales growth to be in the range of one to five percent versus the prior year

Israeli PM Netanyahu says he was diagnosed with early-stage prostate cancer; recently had a successful operation without metastases; asked for a delayed publication amid the war with Iran, Journalist Stein reports

SLB (SLB) Q1 2026 (USD): Adj. EPS 0.52 (exp. 0.52), Revenue 8.72bln (exp. 8.65bln)

SNB Chairman Schlegel says no plans to adjust gold holdings

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

A successful operation suggests he may be able to maintain his leadership role, but uncertainty around his health could impact market sentiment, particularly in energy and gold, as geopolitical risks tend to influence safe-haven assets. Traders should watch for how this situation evolves and its potential implications for regional policies and broader market dynamics.

Related headlines

The whole workspace, free to try.

Try it free